Search

everythinglearnresearchcommunity

for

Search:↓

The treatment increased hair follicle counts and is potentially effective for male hair loss without serious side effects.

Melanoma survivors are more likely to use sunscreen and seek shade than others, but less than half often use sunscreen and avoid the sun, and some still use tanning beds.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

A group has developed therapies that show promise for treating cancer and various other conditions.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Farudodstat may effectively treat alopecia areata without harmful side effects.

Tip cryotherapy effectively treats idiopathic guttate hypomelanosis with minimal side effects.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.

Dupilumab helps children with alopecia areata regrow hair safely.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

The authors agree that standardizing how PRP methods are reported could help compare results, but note that the link between PRP's contents and hair growth is unclear, and recommend avoiding split-scalp designs in future trials.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

5% ET-02 is a more effective and safe treatment for hair loss than current options.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Umbilical cord and cord blood stem cells are promising for treating chronic diseases due to their versatility and ethical acceptability.

The two Eclipta alba varieties can be distinguished by their chemical differences.

Ultraviolet light treatment with trioxsalen was ineffective for vitiligo in the cases described.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Practitioners treating hair loss need better education and resources to overcome challenges like commercial bias and ethical dilemmas.

Sunscreen particles were not found in inflamed or fibrotic areas of skin in FFA patients, suggesting no direct link to the disease.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Companies agreed to stop making false health claims about their products.

The new treatment improved keratosis pilaris symptoms and mood in 28 days.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.